Company Directory / research

PrivateFor profitresearchAgoura Hills, United States
A2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.
Size
51-100 people: larger than 75% of companies with a size listed
Age
8 years old.
Reach
No web traffic ranking listed.
BiotechnologyHealth CareLife Science
Funding, as listed
$191M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about A2 Biotherapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
A2 Biotherapeutics may be growing as indicated by the company's active participation in the American Society of Clinical Oncology (ASCO) Annual Meeting, where they highlighted the progress of their CAR T clinical programs through three poster presentations. This suggests ongoing research and development efforts, which are critical for growth in the biotechnology industry. Additionally, the mention of a C-Suite shuffle implies organizational changes that could be associated with expansion or scaling efforts. The focus on CAR T-cell clinical programs also indicates a specialization in a cutting-edge area of biotechnology, which could position the company for growth within the health care and life science industries.
Summaries written by the source dataset, not by us, and not checked.
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.